PROTEASEVARIANTEN

Patent europeic · EP2510093 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2510093
Numer da la dumonda
EP10803307
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-12-2010
Publitgà
17-10-2012
Concedì
21-02-2018
La protecziun finescha il pli tard
09-12-2030
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C12N 9/58 (2006.01)
Prioritad
US 285601 P 11.12.2009
Dumonda PCT
PCT/US2010/059814 10.12.2010
Publicaziun PCT
WO2011/072191 16.06.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  5. 21-02-2018

    Concedì

    Published in Swissreg on 21.02.2018

Partidas

Possessur

Novozymes A/S

Krogshoejvej 36, 2880 Bagsvaerd, DK

Novozymes North America, Inc.

77 Perry Chapel Church Road, Franklinton, North Carolina 27525, US

Inventur

MATSUI, Tomoko

Chiba 261-0001, JP

NOERGAARD, Allan

Chiba 272-0111, JP

POULSEN, Thomas, Agersten

DK-2750 Ballerup, DK

MATTHEWS, John

Louisburg North Carolina 27549, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.